Nanox to Participate in the Virtual 39th Annual J.P. Morgan Healthcare Conference

NEVE ILAN, Israel and FORT LAUDERDALE, Fla, Jan. 11, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD NNOX ("Nanox" or the "Company"), an innovative medical imaging technology company, today announces that Nanox's Founder and Chief Executive Officer Ran Poliakine will deliver a company presentation and the leadership team will host investor 1x1 meetings during the Virtual 39th Annual J.P. Morgan Healthcare Conference, which is being held from January 11 through January 14.

Mr. Poliakine' s presentation is scheduled for Thursday, January 14, at 9:10am ET. The presentation will be accessible via a live webcast at: https://jpmorgan.metameetings.net/events/healthcare21/sessions/36567-nano-x-vision/webcast?gpu_only=true&kiosk=true

Interested parties can also access the live audio webcast for this conference from the Investor Relations section of the company's website at www.nanox.vision. The webcast replay will be available after the conclusion of the live presentation for approximately 90 days.

About NANO-X:

Nano-X, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nano-X believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.

Contacts:

Investors

Itzhak Maayan

Nanox Imaging

IR@nanox.vision

Bob Yedid

LifeSci Advisors

646-597-6989

bob@lifesciadvisors.com

Media

Alona Stein

ReBlonde for Nanox

alona@reblonde.com



Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!